351 – 360 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Enzymatic action of prostate-specific antigen (PSA or hK3) : Substrate specificity and regulation by Zn2+, a tight-binding inhibitor
(
- Contribution to journal › Article
- 1999
-
Mark
Early Diagnosis and Staging.
(
- Contribution to journal › Article
-
Mark
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects
(
- Contribution to journal › Article
-
Mark
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
(
- Contribution to journal › Article
-
Mark
Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids
(
- Contribution to journal › Article
-
Mark
Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels
(
- Contribution to journal › Article